Explore UBS's top European stock picks with high potential in 2025. Learn why Europe is now overweight and discover stocks ...
UBS upgrades European equities to tactical overweight, citing improved earnings momentum, potential Ukraine ceasefire, and ...
As previously reported, UBS upgraded Interpublic Group (IPG) to Neutral from Sell with a price target of $27, down from $29, citing the firm’s ...
UBS analyst Guillaume Delmas maintained a Sell rating on Unilever (ULVR – Research Report) today and set a price target of £40.50. The ...
UBS has upgraded Roche (OTCQX:RHHBY) to buy from neutral, citing the company's growth outlook. "We see sustained outperformance of Vabysmo and Ocrevus as key drivers of near-term growth, with ...
UBS provided an analysis of the current market regime, earnings, valuations, and sentiment, suggesting that the relative ...